Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Teva
Novartis
Fish and Richardson
Covington
Chubb
McKesson
Daiichi Sankyo
Express Scripts
Mallinckrodt

Generated: January 22, 2018

DrugPatentWatch Database Preview

M.V.I. ADULT Drug Profile

« Back to Dashboard

Which patents cover M.v.i. Adult, and when can generic versions of M.v.i. Adult launch?

M.v.i. Adult is a drug marketed by Hospira and is included in two NDAs.

The generic ingredient in M.V.I. ADULT is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e; vitamin k. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e; vitamin k profile page.
Summary for M.V.I. ADULT
You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE HYDROCHLORIDE','VITAMIN A','VITAMIN E','VITAMIN K') AND hsdb_d' at line 1
US Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: 1